Sanofi 2022 IR
The report outlines Sanofi's progress in 2022, marking the halfway point of its 'Play to Win' strategy. Key achievements include advancing its immunology and vaccine pipelines, launching the Sanofi Global Health Impact Brand to expand medicine access in low-income countries, and establishing Foundation S for philanthropic efforts. Environmentally, the company accelerated its net-zero target to 2045 and implemented water-saving technologies at manufacturing sites. Additionally, Sanofi launched its Diversity, Equity, and Inclusion (DE&I) Board and achieved 42% female representation in senior leadership.
Company: Sanofi
Sector: Health Care
Country: France
Year: 2022
Type: IR
Pages: 43
Sanofi
The report outlines Sanofi's progress in 2022, marking the halfway point of its 'Play to Win' strategy. Key achievements include advancing its immunology and vaccine pipelines, launching the Sanofi Global Health Impact Brand to expand medicine access in low-income countries, and establishing Foundation S for philanthropic efforts. Environmentally, the company accelerated its net-zero target to 2045 and implemented water-saving technologies at manufacturing sites. Additionally, Sanofi launched its Diversity, Equity, and Inclusion (DE&I) Board and achieved 42% female representation in senior leadership.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees